These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 7525047

  • 1. Reversion of the transformed phenotypes of v-H-ras NIH3T3 cells by flavonoids through attenuating the content of phosphotyrosine.
    Kuo ML, Lin JK, Huang TS, Yang NC.
    Cancer Lett; 1994 Nov 25; 87(1):91-7. PubMed ID: 7525047
    [Abstract] [Full Text] [Related]

  • 2. Reversion of v-H-ras-transformed NIH 3T3 cells by apigenin through inhibiting mitogen activated protein kinase and its downstream oncogenes.
    Kuo ML, Yang NC.
    Biochem Biophys Res Commun; 1995 Jul 26; 212(3):767-75. PubMed ID: 7626110
    [Abstract] [Full Text] [Related]

  • 3. Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-ras-transformed NIH 3T3 cells.
    Okura A, Arakawa H, Oka H, Yoshinari T, Monden Y.
    Biochem Biophys Res Commun; 1988 Nov 30; 157(1):183-9. PubMed ID: 2848517
    [Abstract] [Full Text] [Related]

  • 4. Effects of signalling transduction modulators on the transformed phenotypes in v-H-ras-transformed NIH 3T3 cells.
    Kuo ML, Kang JJ, Yang NC.
    Cancer Lett; 1993 Nov 01; 74(3):197-202. PubMed ID: 7513607
    [Abstract] [Full Text] [Related]

  • 5. Flavonoids stimulate Cl conductance of human airway epithelium in vitro and in vivo.
    Illek B, Fischer H.
    Am J Physiol; 1998 Nov 01; 275(5):L902-10. PubMed ID: 9815107
    [Abstract] [Full Text] [Related]

  • 6. Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin.
    Lin JK, Chen YC, Huang YT, Lin-Shiau SY.
    J Cell Biochem Suppl; 1997 Nov 01; 28-29():39-48. PubMed ID: 9589348
    [Abstract] [Full Text] [Related]

  • 7. Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogene.
    Agazie Y, Ischenko I, Hayman M.
    Oncogene; 2002 Jan 24; 21(5):697-707. PubMed ID: 11850798
    [Abstract] [Full Text] [Related]

  • 8. A cytosolic activator of DNA replication is tyrosine phosphorylated in its active form.
    Fresa KL, Autieri MV, Coffman FD, Georgoff I, Cohen S.
    Exp Cell Res; 1993 Apr 24; 205(2):302-10. PubMed ID: 7683270
    [Abstract] [Full Text] [Related]

  • 9. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.
    Dhar A, Paul AK, Shukla SD.
    Mol Pharmacol; 1990 Apr 24; 37(4):519-25. PubMed ID: 1691437
    [Abstract] [Full Text] [Related]

  • 10. Bradykinin B2 receptor-induced and inositol tetrakisphosphate-evoked Ca2+ entry is sensitive to a protein tyrosine phosphorylation inhibitor in ras-transformed NIH/3T3 fibroblasts.
    Hashii M, Nakashima S, Yokoyama S, Enomoto K, Minabe Y, Nozawa Y, Higashida H.
    Biochem J; 1996 Oct 15; 319 ( Pt 2)(Pt 2):649-56. PubMed ID: 8912707
    [Abstract] [Full Text] [Related]

  • 11. Tropomyosin-2 cDNA lacking the 3' untranslated region riboregulator induces growth inhibition of v-Ki-ras-transformed fibroblasts.
    Janssen RA, Mier JW.
    Mol Biol Cell; 1997 May 15; 8(5):897-908. PubMed ID: 9168473
    [Abstract] [Full Text] [Related]

  • 12. Selective inhibition of the growth of ras-transformed human bronchial epithelial cells by emodin, a protein-tyrosine kinase inhibitor.
    Chan TC, Chang CJ, Koonchanok NM, Geahlen RL.
    Biochem Biophys Res Commun; 1993 Jun 30; 193(3):1152-8. PubMed ID: 7686746
    [Abstract] [Full Text] [Related]

  • 13. Activation of Cl- channel and Na+/K+/2Cl- cotransporter in renal epithelial A6 cells by flavonoids: genistein, daidzein, and apigenin.
    Niisato N, Ito Y, Marunaka Y.
    Biochem Biophys Res Commun; 1999 Jan 19; 254(2):368-71. PubMed ID: 9918844
    [Abstract] [Full Text] [Related]

  • 14. Resistance of NIH3T3 cells to v-fes transformation induced by a dominant negative H-ras mutant.
    Ogiso Y, Yokoyama T, Watari H, Shih TY, Kuzumaki N.
    Exp Cell Res; 1993 Oct 19; 208(2):415-21. PubMed ID: 7690710
    [Abstract] [Full Text] [Related]

  • 15. Protein tyrosine kinase inhibitors promote amylase secretion and inhibit ornithine decarboxylase induction in sialagogue-stimulated rat parotid explants.
    Kinoshita F, Ueno A, Miwa Y, Nishino M, Inoue H.
    Biochem Biophys Res Commun; 1996 Jun 05; 223(1):170-4. PubMed ID: 8660365
    [Abstract] [Full Text] [Related]

  • 16. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro.
    Zava DT, Duwe G.
    Nutr Cancer; 1997 Jun 05; 27(1):31-40. PubMed ID: 8970179
    [Abstract] [Full Text] [Related]

  • 17. Suppression of RAS and MOS transformation by radicicol.
    Zhao JF, Nakano H, Sharma S.
    Oncogene; 1995 Jul 06; 11(1):161-73. PubMed ID: 7624124
    [Abstract] [Full Text] [Related]

  • 18. Mitogenic activation of the Ras guanine nucleotide exchange factor in NIH 3T3 cells involves protein tyrosine phosphorylation.
    Li BQ, Subleski M, Shalloway D, Kung HF, Kamata T.
    Proc Natl Acad Sci U S A; 1993 Sep 15; 90(18):8504-8. PubMed ID: 8104337
    [Abstract] [Full Text] [Related]

  • 19. SCH 51344 inhibits ras transformation by a novel mechanism.
    Kumar CC, Prorock-Rogers C, Kelly J, Dong Z, Lin JJ, Armstrong L, Kung HF, Weber MJ, Afonso A.
    Cancer Res; 1995 Nov 01; 55(21):5106-17. PubMed ID: 7585559
    [Abstract] [Full Text] [Related]

  • 20. Phosphotyrosine inhibition and control of vascular endothelial cell proliferation by genistein.
    Koroma BM, de Juan E.
    Biochem Pharmacol; 1994 Aug 17; 48(4):809-18. PubMed ID: 7521641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.